Literature DB >> 31594836

PGC1α Suppresses Prostate Cancer Cell Invasion through ERRα Transcriptional Control.

Lorea Valcarcel-Jimenez1, Alice Macchia1, Verónica Torrano2,3,4, Arkaitz Carracedo2,3,4,5, Eva Crosas-Molist6,7, Ariane Schaub-Clerigué1, Laura Camacho1,3, Natalia Martín-Martín1,4, Paolo Cicogna1, Cristina Viera-Bardón1,4, Sonia Fernández-Ruiz1,4, Irene Rodriguez-Hernandez6,7, Ivana Hermanova1, Ianire Astobiza1,4, Ana R Cortazar1,4, Jon Corres-Mendizabal1, Antonio Gomez-Muñoz3, Victoria Sanz-Moreno6,7.   

Abstract

The PPARγ coactivator 1 alpha (PGC1α) is a prostate tumor suppressor that controls the balance between anabolism and catabolism. PGC1A downregulation in prostate cancer is causally associated with the development of metastasis. Here we show that the transcriptional complex formed by PGC1α and estrogen-related receptor 1 alpha (ERRα) controls the aggressive properties of prostate cancer cells. PGC1α expression significantly decreased migration and invasion of various prostate cancer cell lines. This phenotype was consistent with remarkable cytoskeletal remodeling and inhibition of integrin alpha 1 and beta 4 expression, both in vitro and in vivo. CRISPR/Cas9-based deletion of ERRα suppressed PGC1α regulation of cytoskeletal organization and invasiveness. Mechanistically, PGC1α expression decreased MYC levels and activity prior to inhibition of invasiveness. In addition, PGC1α and ERRα associated at the MYC promoter, supporting the inhibitory activity PGC1α. The inverse correlation between PGC1α-ERRα activity and MYC levels was corroborated in multiple prostate cancer datasets. Altogether, these results support that PGC1α-ERRα functions as a tumor-suppressive transcriptional complex through the regulation of metabolic and signaling events. SIGNIFICANCE: These findings describe how downregulation of the prostate tumor suppressor PGC1 drives invasiveness and migration of prostate cancer cells. ©2019 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31594836     DOI: 10.1158/0008-5472.CAN-19-1231

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

Review 1.  Targeting PGC1α to wrestle cancer: a compelling therapeutic opportunity.

Authors:  Xiangyu Sun; Xiaoyan Liu; Keda Yu; Shouping Xu; Pengfei Qiu; Zhidong Lv; Xinwen Zhang; Yingying Xu
Journal:  J Cancer Res Clin Oncol       Date:  2022-01-15       Impact factor: 4.553

Review 2.  Estrogen-related receptor alpha in select host functions and cancer: new frontiers.

Authors:  Harmit S Ranhotra
Journal:  Mol Cell Biochem       Date:  2022-02-09       Impact factor: 3.396

3.  ERRα expression in ovarian cancer and promotes ovarian cancer cells migration in vitro.

Authors:  Weiyi Huang; Lili Chen; Pengming Sun
Journal:  Arch Gynecol Obstet       Date:  2021-11-19       Impact factor: 2.344

4.  Nuclear Receptors and Lipid Sensing.

Authors:  James L Thorne; Giorgia Cioccoloni
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

5.  CRTC1/MAML2 directs a PGC-1α-IGF-1 circuit that confers vulnerability to PPARγ inhibition.

Authors:  Adele M Musicant; Kshitij Parag-Sharma; Weida Gong; Monideepa Sengupta; Arindam Chatterjee; Erin C Henry; Yi-Hsuan Tsai; Michele C Hayward; Siddharth Sheth; Renee Betancourt; Trevor G Hackman; Ricardo J Padilla; Joel S Parker; Jimena Giudice; Colin A Flaveny; David N Hayes; Antonio L Amelio
Journal:  Cell Rep       Date:  2021-02-23       Impact factor: 9.423

Review 6.  Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches.

Authors:  Nuria Gómez-Cebrián; José Luis Poveda; Antonio Pineda-Lucena; Leonor Puchades-Carrasco
Journal:  Cancers (Basel)       Date:  2022-01-25       Impact factor: 6.639

Review 7.  SLC22A5 (OCTN2) Carnitine Transporter-Indispensable for Cell Metabolism, a Jekyll and Hyde of Human Cancer.

Authors:  Barbara Juraszek; Katarzyna A Nałęcz
Journal:  Molecules       Date:  2019-12-19       Impact factor: 4.411

8.  Genomic and Functional Regulation of TRIB1 Contributes to Prostate Cancer Pathogenesis.

Authors:  Parastoo Shahrouzi; Ianire Astobiza; Ana R Cortazar; Verónica Torrano; Alice Macchia; Juana M Flores; Chiara Niespolo; Isabel Mendizabal; Ruben Caloto; Amaia Ercilla; Laura Camacho; Leire Arreal; Maider Bizkarguenaga; Maria L Martinez-Chantar; Xose R Bustelo; Edurne Berra; Endre Kiss-Toth; Guillermo Velasco; Amaia Zabala-Letona; Arkaitz Carracedo
Journal:  Cancers (Basel)       Date:  2020-09-11       Impact factor: 6.639

Review 9.  Targeting Mitochondrial OXPHOS and Their Regulatory Signals in Prostate Cancers.

Authors:  Chia-Lin Chen; Ching-Yu Lin; Hsing-Jien Kung
Journal:  Int J Mol Sci       Date:  2021-12-14       Impact factor: 5.923

10.  Lipid reprogramming induced by the TFEB-ERRα axis enhanced membrane fluidity to promote EC progression.

Authors:  Xiaodan Mao; Huifang Lei; Tianjin Yi; Pingping Su; Shuting Tang; Yao Tong; Binhua Dong; Guanyu Ruan; Alexander Mustea; Jalid Sehouli; Pengming Sun
Journal:  J Exp Clin Cancer Res       Date:  2022-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.